|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
SCIDIR_ocn967778191 |
| 003 |
OCoLC |
| 005 |
20231120112205.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170106s2017 maua o 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d IDEBK
|d OPELS
|d EBLCP
|d YDX
|d N$T
|d OCLCF
|d UPM
|d OTZ
|d OCLCQ
|d OHS
|d OCLCO
|d D6H
|d MEU
|d OCLCA
|d WYU
|d UKMGB
|d OCLCQ
|d OCLCO
|d SFB
|d OCLCA
|d OCLCO
|d OCLCQ
|
| 015 |
|
|
|a GBB709904
|2 bnb
|
| 016 |
7 |
|
|a 018178018
|2 Uk
|
| 019 |
|
|
|a 968290784
|a 1063631182
|a 1125834180
|a 1197538557
|a 1228649877
|a 1261772158
|
| 020 |
|
|
|a 9780128119150
|q (electronic bk.)
|
| 020 |
|
|
|a 0128119152
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128119143
|q (print)
|
| 020 |
|
|
|a 0128119144
|
| 035 |
|
|
|a (OCoLC)967778191
|z (OCoLC)968290784
|z (OCoLC)1063631182
|z (OCoLC)1125834180
|z (OCoLC)1197538557
|z (OCoLC)1228649877
|z (OCoLC)1261772158
|
| 050 |
|
4 |
|a RC531
|b .A595 2017eb
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.85/22
|2 23
|
| 245 |
0 |
0 |
|a Anxiety /
|c edited by Gerald Litwack.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press is an imprint of Elsevier,
|c 2017.
|
| 300 |
|
|
|a 1 online resource (xvi, 361 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Vitamins and hormones ;
|v volume 103
|
| 546 |
|
|
|a Text in English.
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed January 16, 2017).
|
| 505 |
0 |
|
|a Front Cover; Anxiety; Copyright; Former Editors; Contents; Contributors; Preface; Chapter One: Stress, Anxiety, and Immunomodulation: A Pharmacological Analysis; 1. Introduction; 2. Mechanism of Stress Response; 3. Stress, CNS, and Behavior; 4. Stress and Anxiety; 5. Stress and Various Anxiolytic Drugs; 6. Stress and Immunity; 7. Stress, Anxiety, and Immunomodulation; References; Chapter Two: Estrogen Receptors Modulation of Anxiety-Like Behavior; 1. Introduction; 2. Nuclear Estrogen Receptor Form and Function; 3. Estrogen Receptor Alpha; 4. Estrogen Receptor Beta
|
| 505 |
8 |
|
|a 5. G-Protein-Coupled Estrogen Receptor6. Cross Talk Between Estrogen Receptors; 7. Mechanisms for Estrogen Receptor Effects on Anxiety; 7.1. Effects on the Hypothalamo-Pituitary-Adrenal Axis; 7.2. Effects on the Serotonergic System; 7.3. Effects on the Oxytocinergic System; 8. Conclusions; References; Chapter Three: Neuroendocrine Underpinnings of Increased Risk for Posttraumatic Stress Disorder in Women; 1. Introduction; 1.1. Women and PTSD; 1.2. Sex Differences in the Brain and in Behavior; 1.2.1. Estrogen; 1.2.2. Progesterone/Allopregnanolone
|
| 505 |
8 |
|
|a 1.3. Reproductive Hormones Influence Stress Axis Function1.4. Translational Approaches to Uncovering Sex-Specific Differences in PTSD; 1.4.1. RDoC Constructs; 2. Case Example: PACAP Receptor Genetics; References; Chapter Four: The Big Role of Small RNAs in Anxiety and Stress-Related Disorders; 1. Introduction; 2. Epigenetics; 3. MicroRNAs; 4. Insights into miRNAs Through the Use of Animal Models; 5. Investigating miRNAs in Anxiety Disorders; 5.1. miRSNPs and Variants Within miRNA Genes; 5.2. Differential Expression of miRNAs; 5.3. The Role of miRNAs in Pharmacotherapies for Anxiety Disorders
|
| 505 |
8 |
|
|a 6. ConclusionAcknowledgments; References; Chapter Five: Natriuretic Peptides in Anxiety and Panic Disorder; 1. Neuroendocrine Factors in Anxiety and Fear-Related Disorders; 2. Molecular Mechanisms Involved in Natriuretic Peptide Synthesis; 3. Expression of Natriuretic Peptides and Their Receptors in the Brain; 4. Physiological Actions of Natriuretic Peptides in the Brain; 5. Neuroprotective Effects of Natriuretic Peptides; 6. Evidence of Anxiolytic-Like Effects of ANP; References; Chapter Six: Role of Nitric Oxide in Stress-Induced Anxiety: From Pathophysiology to Therapeutic Target
|
| 505 |
8 |
|
|a 1. Introduction1.1. Stress; 1.2. Anxiety as Response to Stress; 1.3. Nitric Oxide Mechanism in Stress-Induced Anxiety-Like Behavior; 1.4. Mechanisms Leading to Stress-Induced NO Surge; 1.5. Therapeutics Targeting NO Mechanisms in Stress-Induced Anxiety-Like Behavior; 2. Summary; Acknowledgment; References; Chapter Seven: Nitric Oxide and Anxiety; 1. Introduction; 2. Nitric Oxide; 2.1. Biosynthesis of Nitric Oxide; 2.2. NO and Signal Transduction Mechanism; 2.3. Nitric Oxide and Central Nervous System; 2.4. Nitric Oxide-Cytotoxicity vs Cytoprotection: A Question of Balance
|
| 504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
| 650 |
|
0 |
|a Anxiety.
|
| 650 |
|
0 |
|a Anxiety disorders.
|
| 650 |
|
2 |
|a Anxiety
|0 (DNLM)D001007
|
| 650 |
|
2 |
|a Anxiety Disorders
|0 (DNLM)D001008
|
| 650 |
|
6 |
|a Troubles anxieux.
|0 (CaQQLa)201-0284655
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Anxiety.
|2 fast
|0 (OCoLC)fst00810950
|
| 650 |
|
7 |
|a Anxiety disorders.
|2 fast
|0 (OCoLC)fst01738149
|
| 700 |
1 |
|
|a Litwack, Gerald,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Anxiety.
|d Cambridge, MA : Academic Press is an imprint of Elsevier, 2017
|z 0128119144
|z 9780128119143
|w (OCoLC)959872231
|
| 830 |
|
0 |
|a Vitamins and hormones ;
|v v. 103.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/00836729/103
|z Texto completo
|
